Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 149 results found. Search for [ Merck ]

Results 80 to 100 of 149
P.B. Jayakumar
July 8, 2015
As part of our Emerging Companies 2015 special, we profile the company that is a perfect example of a venture that had a slow start but over the years managed to build a base for a strong takeoff.

E Kumar Sharma
June 3, 2015
Speaking to Business Today, Jaideep Gogtay, Chief Medical Officer, Cipla said: \"Lopinavir/Ritonavir is a preferred antiretroviral in pediatric patents.

E Kumar Sharma
May 16, 2015
For, if the current order is any indication, it is not as if application of patent law has any domestic industry bias or that effective judicial remedy is not available.

Zeba Siddiqui and Nivedita Bhattacharjee
Mumbai, May 15, 2015
The court has, however, allowed Glenmark to continue to sell existing inventory, the sources said.

E. Kumar Sharma
March 25, 2015
With this, analysts feel, Glenmark Pharmaceuticals gets a respite for the moment as it can resume sales of its medicines Zeta and Zeta-met used to treat diabetes.

Mail Today Bureau
New Delhi, March 21, 2015
The court barred the pharma company from making, marketing or selling its anti-diabetes medicines on the ground that it had prima facie infringed the patent of Merck Sharp and Dohme (MSD).

New Delhi, March 3, 2015
Out of 509 drugs, above 40 per cent price reduction has happened in the case of 127 essential medicines, while prices of 34 drugs has come down in the range of 35-40 per cent,

Zeba Siddiqui
Mumbai, December 12, 2014
Besides commonly-used antibiotics and pain-killers, the new drugs to come under price control include medicines used for treating cancer and skin disorders.

Sanjeev Jha
November 17, 2014
From a business model innovation perspective, I believe the companies need to leverage both their wealth of experience and market realities.

Zeba Siddiqui
Mumbai, October 28, 2014
India's second-largest drugmaker by market value has posted a net profit of Rs 6.3 billion for the quarter ended September 30.

E Kumar Sharma
September 30, 2014
D.G. Shah, Secretary General of the Indian Pharmaceutical Alliance (IPA) said: \"Only a sober face of US branded pharma was invited to the breakfast meeting with PM Narendra Modi.

New York, September 24, 2014
Narendra Modi will hold a breakfast meeting with the CEOs of 11 top US companies on September 29 during his maiden visit to the United States as prime minister.

Chennai, September 18, 2014
Merck will continue all clinical development and regulatory activities, which will be funded by Sun Pharma.

Mumbai, September 18, 2014
The Federal Reserve policy announcement on Wednesday night allayed fears of capital outflows.

New Delhi, September 16, 2014
This strategic partnership builds on the existing close collaboration between the two companies and adds up to 20 new products to the current portfolio, Lupin said.

Natalie Grover and Zeba Siddiqui
Mumbai, September 16, 2014
Epirus Biopharmaceuticals said that the domestic drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the India early next year.

E. Kumar Sharma
September 18, 2014
Not all Indian bulk drug makers are reeling before the Chinese onslaught. Some have honed their processes to become world leaders in niche areas.

New Delhi, August 13, 2014
Standalone net sales of the company also rose to Rs 232.64 crore for the quarter under consideration as against Rs 200.29 crore for the same period year ago.

Sophie Sassard and Zeba Siddiqui
July 22, 2014
GSK is looking to divest the mature products in a bid to improve its growth profile and wants to dispose of off-patent drugs marketed in North America and western Europe with annual sales of around 1 billion pounds ($1.7 billion).

Ben Hirschler
London, May 27, 2014
The fight was actually lost a week earlier after an angry stand-off on Sunday May 18 in which both sides blamed each other for closing down talks on a $118 billion offer that was \"only\" about $8 billion adrift from the price AstraZeneca wanted.

PAGES 5 OF 8  12345